Caprock Group, Inc. Bausch Health Companies Inc. Transaction History
Caprock Group, Inc.
- $4.51 Billion
- Q4 2025
A detailed history of Caprock Group, Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Caprock Group, Inc. holds 49,740 shares of BHC stock, worth $312,367. This represents 0.01% of its overall portfolio holdings.
Number of Shares
49,740Holding current value
$312,367% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BHC
# of Institutions
268Shares Held
204MCall Options Held
2.54MPut Options Held
6.46M-
John Paulson Paulson & Co. Inc. | New York, Ny70.8MShares$444 Million16.32% of portfolio
-
Nomura Holdings Inc Tokyo, M015.7MShares$98.6 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$81.6 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$67.1 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A610.5MShares$66 Million0.01% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.27B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...